[1]刘冠虹,吉万波,刘锦涛,等.股密葆方治疗早中期非创伤性股骨头坏死肾虚血瘀证的临床研究[J].中医正骨,2022,34(02):12-14+23.
　LIU Guanhong,JI Wanbo,LIU Jintao,et al.A clinical study of oral application of Gumibao Fang(股密葆方)for treatment of early- and mid-stage non-traumatic osteonecrosis of the femoral head with kidney-deficiency and blood-stasis syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2022,34(02):12-14+23.
点击复制

股密葆方治疗早中期非创伤性股骨头坏死肾虚血瘀证的临床研究()
分享到：

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第34卷
期数:
2022年02期
页码:
12-14+23
栏目:
临床研究
出版日期:
2022-02-20

文章信息/Info

Title:
A clinical study of oral application of Gumibao Fang(股密葆方)for treatment of early- and mid-stage non-traumatic osteonecrosis of the femoral head with kidney-deficiency and blood-stasis syndrome
作者:
刘冠虹; 吉万波; 刘锦涛; 姜宏
南京中医药大学附属苏州市中医医院,江苏 苏州 215009
Author(s):
LIU Guanhong; JI Wanbo; LIU Jintao; JIANG Hong
Suzhou Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine,Suzhou 215009,Jiangsu,China
关键词:
股骨头坏死;  股密葆方;  治疗结果;  存活率分析
Keywords:
femur head necrosis;  Gumibao prescription;  treatment outcome;  survival analysis
摘要:
目的:观察股密葆方治疗早中期非创伤性股骨头坏死肾虚血瘀证的临床疗效。方法:2010年1月至2018年12月收治57例(61髋)非创伤性股骨头坏死肾虚血瘀证患者,男33例、女24例; 年龄28～63岁,中位数41岁; 国际骨微循环研究学会(association research circulation osseous,ARCO)分期Ⅰ期7髋、Ⅱ期41髋、ⅢA期13髋。均采用口服股密葆方治疗,每日1剂,水煎服,早晚各1次,3个月为1个疗程,共治疗4个疗程。采用Harris髋关节评分标准和欧洲五维健康量表(EuroQol-5 dimension,EQ-5D)进行疗效评价。治疗及随访期间复查双侧髋关节正位、蛙位X线片,记录观察时间及患髋ARCO分期,以ARCO分期超过ⅢA期为塌陷标准,作为观察终点进行生存分析。结果:所有患者均观察随访至治疗开始后2年以上(治疗开始后25～76个月,中位数43个月)。至观察结束时,共有13髋发生塌陷(进展至ⅢA期以上),其中Ⅱ期8髋(19.51%)、ⅢA期5髋(38.46%)。股骨头生存时间(64.51±3.61)个月,中位生存时间66个月。治疗开始后2年时,患者的Harris髋关节评分总分及其中的疼痛评分、关节功能评分、关节活动度评分均较治疗前提高[(73.58±10.02)分,(84.92±7.56)分,t=3.130,P=0.016;(32.25±6.17)分,(38.67±5.06)分,t=4.210,P=0.000;(34.42±5.85)分,(39.00±3.66)分,t=3.960,P=0.000;(3.25±0.53)分,(4.35±0.53)分,t=2.100,P=0.023],关节畸形评分与治疗前的差异无统计学意义[(3.67±1.13)分,(3.50±1.35)分,t=-1.460,P=0.230]; EQ-5D指数也较治疗前提高(0.54±0.16,0.66±0.13,t=2.300,P=0.021)。结论:采用股密葆方治疗早中期非创伤性股骨头坏死肾虚血瘀证,可有效缓解髋关节疼痛、改善髋关节功能,提高患者生活质量,延缓股骨头塌陷。
Abstract:
Objective:To observe the clinical outcome of oral application of Gumibao Fang(股密葆方,GMBF)in treatment of early- and mid-stage non-traumatic osteonecrosis of the femoral head(NONFH)with syndrome of kidney-deficiency and blood-stasis.Methods:Fifty-seven kidney-deficiency-blood-stasis-type NONFH patients(61 hips)recruited from January 2010 to December 2018 were enrolled in the study,and they consisted of 33 males and 24 females and ranged in age from 28 to 63 years(Median=41 yrs).According to the staging standard issued by the association research circulation osseous(ARCO),the NONFH belonged to ARCO stageⅠin 7 hips,stageⅡin 41 hips and stageⅢA in 13 hips.All patients were treated with oral application of GMBF,one dose a day in the morning and evening respectively for consecutive 4 courses of treatment,3 months for each course.The clinical outcome was evaluated according to Harris hip score(HHS)and EuroQol-5 dimension(EQ-5D).The X-ray examination of bilateral hip in normotopia and froglike position were performed during the treatment and follow-up period.The observation timepoints and ARCO stage of the affected hips were recorded.The observation was terminated when ARCO stage of the hips was beyond ARCO stageⅢA,which was considered as the criterion of collapse,and the survival analysis was conducted.Results:All patients were followed up for 25-76 months(Median=43 months)after the start of treatment.By the end of follow-up,the collapse was found in 13 hips(stageⅢA or above),among which 8 hips at stageⅡ(19.51%)and 5 hips at stageⅢA(38.46%).The survival time of femur head was 64.51±3.61 months with a median of 66 months.The HHSs including total scores,pain scores,function scores and scores of range of motion were higher at 2 years after the start of treatment compared to pre-treatment (73.58±10.02 vs 84.92±7.56 points,t=3.130,P=0.016; 32.25±6.17 vs 38.67±5.06 points,t=4.210,P=0.000; 34.42±5.85 vs 39.00±3.66 points,t=3.960,P=0.000; 3.25±0.53 vs 4.35±0.53 points,t=2.100,P=0.023),while there was no statistical difference in joint deformity scores between the 2 timepoints(3.67±1.13 vs 3.50±1.35 points,t=-1.460,P=0.230).Furthermore,the EQ-5D index increased at 2 years after the start of treatment compared to pre-treatment(0.54±0.16,0.66±0.13,t=2.300,P=0.021).Conclusion:Oral application of GMBF can effectively relieve the hip pain,improve hip function,delay femoral head collapse and improve patient's life quality in treatment of early-middle NONFH with kidney-deficiency and blood-stasis syndrome.

参考文献/References:

[1] MONT M A,HUNGERFORD D S.Non-traumatic avascular necrosis of the femoral head[J].J Bone Joint Surg Am,1995,77(3):459-474.
[2] ZALAVRAS C G,LIEBERMAN J R.Osteonecrosis of the femoral head:evaluation and treatment[J].J Am Acad Orthop Surg,2014,22(7):455-464.
[3] ZHAO D W,YU M,HU K,et al.Prevalence of Nontrau-matic osteonecrosis of the femoral head and its associated risk factors in the Chinese population:results from a nationally representative survey[J].Chin Med J(Engl),2015,128(21):2843-2850.
[4] 雷志强,曾平,陈卫衡,等.股骨头坏死流行病学特点分析[J].中医正骨,2020,32(1):4-6.
[5] ZALAVRAS C G,LIEBERMAN J R.Osteonecrosis of the femoral head:evaluation and treatment[J].J Am Acad Orthop Surg,2014,22(7):455-464.
[6] 张鹤山,李子荣.股骨头坏死诊断与治疗的专家建议[J].中华骨科杂志,2007,27(2):146-148.
[7] 郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:354.
[8] GARDENIERS J W M.A new international classification of osteonecrosis of the ARCO-committee on terminology and classification[J].ARCO News Letter,1992,4:41.
[9] HARRIS W H.Traumatic arthritis of the hip after dislocation and acetabular fractures:treatment by mold arthroplasty.An end-result study using a new method of result evaluation[J].J Bone Joint Surg Am,1969,51(4):737-755.
[10] 田斐,高建民,郭海涛,等.欧洲五维度健康量表(EQ-5D)研究与应用概况[J].卫生经济研究,2007(9):42.
[11] MONT M A,ZYWIEL M G,MARKER D R,et al.The natural history of untreated asymptomatic osteonecrosis of the femoral head:a systematic literature review[J].J Bone Joint Surg Am,2010,92(12):2165-2170.
[12] 吉万波,刘冠虹,刘锦涛,等.中药股密葆治疗大鼠激素性股骨头坏死的生物力学作用机理研究[J].中国中医骨伤科杂志,2013,21(9):7-10.
[13] 宋奕,姜宏,丁道芳,等.股密葆含药血清对高浓度地塞米松干预后成骨细胞增殖分化作用的影响[J].中国骨伤,2014,27(8):668-672.
[14] 吉万波,刘冠虹,刘锦涛,等.益气化瘀补肾法对大鼠激素性股骨头坏死骨代谢的影响[J].广州中医药大学学报,2014,31(2):239-242.
[15] 吉万波,刘冠虹,刘锦涛,等.股密葆方对大鼠激素性股骨头坏死脂质代谢影响的实验研究[J].中国骨质疏松杂志,2016,22(12):1580-1584.

相似文献/References:

[1]陈雷雷,张颖.何伟教授采用中医药疗法治疗股骨头坏死的经验[J].中医正骨,2015,27(10):74.
[2]徐西林,赵永兰,张晓峰,等.活骨注射液髋关节腔灌注对兔股骨头坏死模型 血管内皮生长因子表达的动态影响[J].中医正骨,2015,27(08):1.
　XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(02):1.
[3]周勇,任菲菲,丰凡翔,等.血管内皮生长因子和骨形态发生蛋白2 在非创伤性股骨头坏死不同区域的表达[J].中医正骨,2015,27(08):7.
　ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(02):7.
[4]鲍荣华,王国平,夏晓斌,等.钽棒植入治疗非创伤性股骨头坏死的疗效观察[J].中医正骨,2015,27(02):28.
[5]张兵,马凰富,刘波,等.非创伤性股骨头坏死的舌象定量研究[J].中医正骨,2015,27(04):8.
　ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(02):8.
[6]李刚,程春生.股骨头坏死血瘀证症状与平乐郭氏正骨方药药物组成 最大频繁关联模式挖掘[J].中医正骨,2015,27(04):21.
　LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(02):21.
[7]李文龙,梅沉成,杜贵强,等.微创减压植骨多孔钽棒植入治疗 ARCOⅡ期非创伤性缺血性股骨头坏死[J].中医正骨,2016,28(02):43.
[8]张磊,金红婷,童培建.骨健口服液早期干预非创伤性股骨头坏死的临床研究[J].中医正骨,2016,28(03):14.
　ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(02):14.
[9]鲍荣华,王国平,夏晓斌,等.直接前入路微创全髋关节置换术治疗晚期股骨头坏死[J].中医正骨,2016,28(03):61.
[10]张超,姚晨,沈计荣.微创髓芯减压打压支撑植骨术结合补肾活血汤口服治疗ARCOⅡ、Ⅲ期股骨头坏死的近期疗效观察[J].中医正骨,2016,28(03):20.
　ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(02):20.

备注/Memo

备注/Memo:
基金项目:江苏省基础研究计划青年基金项目(BK20210102)
通讯作者:姜宏 E-mail:honghong751@126.com
更新日期/Last Update: 2022-02-20